Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Pharma

Healthcare systems will remain under increased pressure of cyberattacks even after COVID-19 outbreak ends

With the scale and complexity of cybercrime increasing, and the fact that hospitals are moving toward digitalization and remote patient care, the number of cyberattacks on healthcare systems will continue to increase, says GlobalData, a leading data and analytics company. Urte Jakimaviciute, MSc, Senior Director of Market Research at GlobalData, comments: “Since the emergence of […]
Read more

Lack of patient selection holds back new combinations in melanoma

Targeted therapies have delivered on their promise to make oncology more personalized. However, the addition of immunotherapy agents without first testing for patients who are most likely to benefit may limit the success of triplet combinations in melanoma, says GlobalData, a leading data and analytics company. The addition of Tecentriq (atezolizumab) to a doublet therapy […]
Read more

FDA new drug approvals down 16% in 2019

In 2019 the US Food and Drug Administration (FDA) accepted 119 New Drug Approvals (NDAs) and Biologics License Applications (BLAs) including New Molecular Entities (NMEs) and new formulations of older drugs. This figure represents a 3% increase over the 2014–2018 period average of 115 approvals, but is a 16% decrease on 2018’s 137 approvals, according […]
Read more

ICMR banks on Bharat Biotech expertise to develop COVID-19 vaccine in India, says GlobalData

Following the news that Indian Council of Medical Research (ICMR) and India-based Bharat Biotech have partnered to develop an indigenous COVID-19 vaccine; Anupama, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “ICMR selected Bharat Biotech due to its expertise in indigenous vaccine development. COVID-19 virus isolate obtained from ICMR’s National […]
Read more

Fujifilm and Ansun’s efforts to repurpose their influenza therapies to treat COVID-19 draw efficacy skepticism

With Fujifilm Toyama Chemical’s Avigan (favipiravir) already approved in Japan for influenza, that country had announced plans to stockpile two million courses of the oral drug for COVID-19, but reporting by Reynald Castañeda, Pharma Writer for the Investigative News team at GlobalData, a leading data and analytics company, notes that there are reservations about the drug’s potential in treating […]
Read more

BCG vaccines being tested for protection against COVID-19

As the COVID-19 pandemic continues to spread, researchers are examining reasons why various countries were impacted differently. It has been suggested that the severity of COVID-19 is higher in countries that do not have a history of Bacillus Calmette–Guerin (BCG) vaccination programs. Clinical trials are underway to investigate the possibility that they confer some immunity […]
Read more

COVID-19 pandemic could cause increase in prevalence of PTSD

A significant increase in the total prevalence of PTSD is expected globally amid the COVID-19 pandemic – with the risk for women being twice as high as men, says GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Post-Traumatic Stress Disorder: Epidemiology Forecast to 2028’, notes that the 12-month total prevalence of PTSD in the […]
Read more

China’s blockchain-backed recovery from COVID-19 could pave way to create efficient disease surveillance system, says GlobalData

Despite the COVID-19 outbreak, China managed to launch its national blockchain-based service network (BSN) in April 2020, as scheduled earlier, in an attempt to promote the mass adoption of blockchain and explore the opportunities that the digital economy can bring. China has been an early adopter of technologies to fight COVID-19 and will be closely observed […]
Read more

Success of new research projects crucial in containing community spread of COVID-19 in India, says Globaldata

The Department of Science and Technology – Science and Engineering Board (DST-SERB) has recently initiated several special research projects. These efforts could help contain community spread of the novel coronavirus (COVID-19) in India, says GlobalData, a leading data and analytics company. According to GlobalData COVID-19 dashboard, as of 05 May 2020, India has 46,437 confirmed cases […]
Read more

Calibrated financial support to bolster India’s preparedness in fight against COVID-19, says GlobalData

Following the news that India has approved nearly US$2bn* towards ‘India COVID-19 Emergency Response and Health System Preparedness Package’; Sasmitha Sahu, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “The move comes as no surprise as the COVID-19 situation has seen some unprecedented decisions taken swiftly by the Indian government. […]
Read more
1 … 94 95 96 97 98 … 110